Spell Capital Partners

o15 Capital Partners Announces Approval of First SBIC License and Recent Additions to the Team

Retrieved on: 
Tuesday, November 14, 2023
SBA, Government, Knudsen, Small business, Small Business Administration, Fund, Spell Capital Partners, SBIC

ATLANTA, Nov. 14, 2023 /PRNewswire/ -- o15 Capital Partners ("o15"), today announced its approval by the Small Business Administration (SBA) for the firm's first Small Business Investment Company (SBIC) license.

Key Points: 
  • ATLANTA, Nov. 14, 2023 /PRNewswire/ -- o15 Capital Partners ("o15"), today announced its approval by the Small Business Administration (SBA) for the firm's first Small Business Investment Company (SBIC) license.
  • The license will provide the firm with access to investment of up to $175 million in government leverage for its inaugural Emerging America Credit Opportunities ("EACO") Fund I.
  • In addition to receiving its SBIC license, o15 has also made several key hires to the firm's operation and investment teams including CFO Vil Knudsen, Principal Javier Davila, and Vice President Seth Boyles.
  • Knudsen brings over 20 years of financial and operational expertise including direct experience with the SBIC.

Sheridan Capital Partners Announces Formation of Ascend Plastic Surgery Partners

Retrieved on: 
Friday, October 27, 2023
Surgery, Finance, Business, Professional Services, Practice Management, Other Health, Health, General Health, Other Professional Services, Day, Physician, Spell Capital Partners, Partnership, Partner, Patient, McDermott Will & Emery, Dentistry, Hospital

Sheridan Capital Partners (“Sheridan”) announced today the formation of Ascend Plastic Surgery Partners (“Ascend” or the “Company”), a plastic surgery physician practice management company.

Key Points: 
  • Sheridan Capital Partners (“Sheridan”) announced today the formation of Ascend Plastic Surgery Partners (“Ascend” or the “Company”), a plastic surgery physician practice management company.
  • Today, Ascend represents the combination of five plastic surgery practices and two standalone MedSpas.
  • Sheridan partnered with Dr. Hedden, along with a team of accomplished physicians, to establish Ascend Plastic Surgery Partners.
  • The transaction was led by Jonathan Lewis, Nicholas Rowland, Christopher McCrory, Stephen Lestyan, and Munib Ansari at Sheridan Capital Partners.

Exome Asset Management Names Alex Forschner and Joseph Narvaez to Corporate Office

Retrieved on: 
Wednesday, September 6, 2023
Asset Management, Professional Services, Finance, Senior, Partner, NetworkManager, Partner (business rank), Assets under management, Spell Capital Partners, Corporate Office Properties Trust, OrbiMed, AUM, Office, Corporation, Madison Avenue, Growth, Security (finance), Exome

Exome Asset Management LLC (“Exome”), an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, today announced that Alex Forschner and Joseph Narvaez have joined Managing Partner and Founder Sam Isaly as Partners in the firm’s Corporate Office.

Key Points: 
  • Exome Asset Management LLC (“Exome”), an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, today announced that Alex Forschner and Joseph Narvaez have joined Managing Partner and Founder Sam Isaly as Partners in the firm’s Corporate Office.
  • Mr. Forschner has been promoted to President and Mr. Narvaez has been promoted to Chief Operating Officer.
  • Both Mr. Forschner and Mr. Narvaez are founding Partners of the firm.
  • Prior to joining Exome, Mr. Narvaez served as a Network Manager at OrbiMed Advisors LLC, where he managed the firm’s IT systems.

P3 Health Partners Announces Second-Quarter 2023 Results

Retrieved on: 
Monday, August 7, 2023
Managed Care, General Health, Health, Practice Management, Medicine, PIII, Spell Capital Partners, Life Partners, Inc., PMPM, Patient, Pharmaceutical industry, Video game, Bookkeeping, P3

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2023.

Key Points: 
  • P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2023.
  • “The results for the second quarter of 2023 show the power and trajectory of the P3 model.
  • The strength we have seen in 2023 has given us the stability and momentum to drive our next phase of success in 2024, and beyond,” said Dr. Sherif Abdou, CEO of P3.
  • That is a reflection of the effectiveness of P3’s model and the increasing maturity of the membership on P3’s platform.

35+ Companies Join Bunker Labs' America's Business Mission to Support Veteran and Military Spouse Entrepreneurship

Retrieved on: 
Wednesday, June 28, 2023
Spell Capital Partners, Organization, Ecosystem, Business partner, Entrepreneurship, Dream, Education, Business, Management

CHICAGO, June 28, 2023 /PRNewswire/ -- Today, Bunker Labs launched America's Business Mission to rally business and civic leaders around military entrepreneurship.

Key Points: 
  • CHICAGO, June 28, 2023 /PRNewswire/ -- Today, Bunker Labs launched America's Business Mission to rally business and civic leaders around military entrepreneurship.
  • "America's Business Mission is a call to action for business and civic leaders to support and connect with veteran and military spouse entrepreneurs," says Blake Hogan, CEO of Bunker Labs.
  • America's Business Mission is all about building bridges for veteran and military spouse entrepreneurs to access capital, resources, and networks."
  • Business Partners fund Bunker Labs operations with a donation, while Capital Partners work with Bunker Labs to provide more capital access opportunities to Bunker Labs' veteran and military spouse entrepreneurs.

Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth

Retrieved on: 
Thursday, April 27, 2023
Spell Capital Partners, KKR, Sale

Biosynth is owned, amongst others, by KKR, Ampersand Capital Partners and management.

Key Points: 
  • Biosynth is owned, amongst others, by KKR, Ampersand Capital Partners and management.
  • The Company has used approximately $11 million of the proceeds of the sale to repay approximately $10.1 million of its senior secured debt held by Perceptive Advisors plus an approximately $900,000 early repayment penalty.
  • In connection with this transaction, the Company has entered into an amendment to its senior secured term loan credit facility with Perceptive Advisors, which significantly reduces the Company’s minimum revenue covenants under that loan.
  • Trinity Biotech wishes the Fitzgerald Industries team and Biosynth all the very best for the future.

Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth

Retrieved on: 
Thursday, April 20, 2023
Spell Capital Partners, FitzGerald, Trinity, KKR, Sale, EBITDA, Bank

Life sciences supply is no longer core to Trinity Biotech’s refined long-term strategy.

Key Points: 
  • Life sciences supply is no longer core to Trinity Biotech’s refined long-term strategy.
  • The Fitzgerald life sciences supply business generated revenue of approximately $12 million in the year ended 31 December 2022, and was EBITDA positive.
  • The approximately $30 million cash proceeds from Biosynth includes funding to Fitzgerald Industries to allow it repay intercompany loans owed to Trinity Biotech.
  • The Company believes that Biosynth, a supplier of critical raw materials to the life sciences industry, is an excellent fit for Fitzgerald Industries, and that Fitzgerald Industries will continue to flourish as part of Biosynth.

Precision Production Fortifies its Acquisition Focus with Strategic Hire

Retrieved on: 
Thursday, April 13, 2023
ASG, Growth, Sumitomo Precision Products, OEM, Jergens, Spell Capital Partners, Pacific Rim, Acquisition, Precision, Management

STRONGSVILLE, Ohio, April 13, 2023 /PRNewswire/ -- Precision Production LLC today announced the hiring of former Jergens ASG Division Vice President, Bryon N. Shafer, as its Chief Operating Officer.

Key Points: 
  • STRONGSVILLE, Ohio, April 13, 2023 /PRNewswire/ -- Precision Production LLC today announced the hiring of former Jergens ASG Division Vice President, Bryon N. Shafer, as its Chief Operating Officer.
  • Shafer, with over 20 years of experience in Operations and M&A, will work with current management to drive Precision's acquisition strategy.
  • Precision Production began operations in 1995 and produces machined components for industrial OEM's, with an established network of manufacturing partners throughout the Pacific Rim.
  • It is actively seeking quality strategic acquisitions, most recently having purchased Calumet Screw Machine Products of Mokena, Illinois in 2021.

Turnspire Capital Partners Acquires USG Water Solutions From Veolia

Retrieved on: 
Monday, February 27, 2023
Finance, Natural Resources, Professional Services, Other Professional Services, Other Natural Resources, USG, LLP, Engineering, Water quality, Growth, Nalco Water, Spell Capital Partners, Water, Management, Veolia

Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has acquired USG Water Solutions, LLC (“USG” or the “Company”) from Veolia North America, the U.S. holding company of Veolia Environnement S.A. (“Veolia”).

Key Points: 
  • Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has acquired USG Water Solutions, LLC (“USG” or the “Company”) from Veolia North America, the U.S. holding company of Veolia Environnement S.A. (“Veolia”).
  • Turnspire is also pleased to announce the appointment of John C. Flaugher as President and Chief Executive Officer of USG.
  • Headquartered in Atlanta and Perry, Georgia, USG Water Solutions is the leading provider of water asset management services for small and medium public water utilities in North America.
  • USG’s offerings include maintenance services for water storage tanks, pipe networks, and concrete structures in water and wastewater plants.

SunTx Capital Partners Named a 2023 Top 50 Private Equity Firm in the Middle Market for the Third Consecutive Year

Retrieved on: 
Tuesday, February 21, 2023
III, Investment, Spell Capital Partners, Security (finance)

DALLAS, Feb. 21, 2023 /PRNewswire/ -- SunTx Capital Partners ("SunTx"), a Dallas, TX-based private equity firm that invests in middle market manufacturing, distribution, and service companies, was named one of the 2023 TOP 50 PE Firms in the Middle Market .

Key Points: 
  • DALLAS, Feb. 21, 2023 /PRNewswire/ -- SunTx Capital Partners ("SunTx"), a Dallas, TX-based private equity firm that invests in middle market manufacturing, distribution, and service companies, was named one of the 2023 TOP 50 PE Firms in the Middle Market .
  • Founded in 2016, the Top 50 PE Firms in the Middle Market is an awards program designed specifically to acknowledge highly reputable, small and mid-sized private equity firms that have superb teams, exceptional track records, and demonstrate significant deal and fundraising activity.
  • "It is an honor to be recognized as one of the Top 50 PE Firms in the Middle Market.
  • We are proud to support these leading middle market private equity firms whose relentless pursuit of excellence leads to significant advantages for their portfolio companies and limited partners."